Migraine Trial, Recruiting NCT07279623 Sponsor: Abilion Medical Systems AB Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT07279623
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old at the time of screening.
  • You have been officially diagnosed by a doctor with migraine without aura, migraine with aura, or chronic migraine.
  • Your migraines first started before you turned 50 years old.
  • You have had migraines for at least 1 year before joining the study.
  • You experience at least 8 migraine days per month during the screening period.
  • If you currently take medication to prevent migraines, your dose and type must have been stable for the past 3 months, and you must be willing to keep it unchanged throughout the study.
  • You are willing to sign a consent form and attend all required study visits and assessments.
  • If you are a woman who could become pregnant, you must agree to use a reliable, medically approved form of birth control for the entire duration of the study.
  • You are expected to follow the treatment plan and attend all follow-up appointments.

Who may not be able to join:

  • You have difficulty telling the difference between your migraines and other types of headaches.
  • You have had nasal or sinus surgery within the past 12 months.
  • You have a serious health condition that the study doctor believes could make participation unsafe or affect the study results.
  • You have taken part in another clinical trial or used an experimental drug or device within the past 30 days.
  • You are currently pregnant, breastfeeding, or planning to become pregnant during the study.
  • You have a cognitive difficulty or language barrier that would prevent you from fully understanding or participating in the study (confirm with trial site).
  • The study doctor determines you are unsuitable to participate for any other reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jan-Erik Juto, PhD, MD

Phone: +46(0)739808065

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Abilion Medical Systems AB
Registry
ClinicalTrials.gov
Start date
21 October 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Change in Monthly Migraine Days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov